Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Donate to our blog

Your support will help Science & Enterprise continue to provide science news for business people and business news for scientists.

Blood Stem Cell Start-Up Launches, Earns $48.5M Funding

A new enterprise, spun-off from Harvard University stem cell labs, aims to make stem cell transplants from bone marrow safer and more reliable. . . . → Read More: Blood Stem Cell Start-Up Launches, Earns $48.5M Funding

Fertility Device Company Gains $9.7M in Early Funds

A two year-old medical device enterprise making a fertility tracker for women is raising $9.7 million in its first venture finance round. . . . → Read More: Fertility Device Company Gains $9.7M in Early Funds

Oxford, Evotec Partner on Drug Discovery

A collaboration between University of Oxford and a German drug discovery company aims to speed promising new treatments to the market, including support for start-up enterprises. . . . → Read More: Oxford, Evotec Partner on Drug Discovery

Crowdfunded Digital Health Investment Fund Launches

An investment fund raising its capital through crowdfunding began operations this week to back start-up enterprises developing digital health technologies. . . . → Read More: Crowdfunded Digital Health Investment Fund Launches

Institutes, Companies Form Business to Bridge Discovery Gap

Three research institutions with pharmaceutical and venture capital companies are creating a new enterprise to fill the drug development gap between proof-of-concept and initial clinical trials. . . . → Read More: Institutes, Companies Form Business to Bridge Discovery Gap

Google Acquires Visual Interaction Tech Company

Google is acquiring Eyefluence Inc., developer of a technology that allows individuals to interact with computers, phones, and other devices using only their eyes. . . . → Read More: Google Acquires Visual Interaction Tech Company

3-D Printing Creates Heart-on-Chip with Sensors

Biomedical engineers at Harvard University developed a programmable and automated process for creating miniature organs on chips with integrated sensors using 3-D printing. . . . → Read More: 3-D Printing Creates Heart-on-Chip with Sensors

Start-Up to Commercialize New Parkinson’s Treatment

Mavalon Therapeutics, a new company in the U.K., is being formed to bring a treatment to market that stops the progression of Parkinson’s disease. . . . → Read More: Start-Up to Commercialize New Parkinson’s Treatment

Harvard Spin-Off to Sequence, Visualize RNA in Tissue

A new spin-off enterprise from Harvard University is commercializing technology that enables sequencing and imaging of genetic transcriptions of cells in their original tissue. . . . → Read More: Harvard Spin-Off to Sequence, Visualize RNA in Tissue

Spin-Off Companies to Develop Chronic Disease Therapies

Two new spin-off enterprises are being created to develop gut-based treatments for chronic diseases using technologies from synthetic biology company Intrexon Corporation. . . . → Read More: Spin-Off Companies to Develop Chronic Disease Therapies